Identification and pharmaceutical evaluation of novel frog skin-derived serine proteinase inhibitor peptide–PE-BBI (Pelophylax esculentus Bowman-Birk inhibitor) for the potential treatment of cancer
Peng Lyu, Lilin Ge, Rui Ma, Ran Wei, Cian McCrudden, Tianbao Chen, Chris Shaw, Hang fai Kwok
Dive into the research topics of 'Identification and pharmaceutical evaluation of novel frog skin-derived serine proteinase inhibitor peptide–PE-BBI (Pelophylax esculentus Bowman-Birk inhibitor) for the potential treatment of cancer'. Together they form a unique fingerprint.